Haidet AM, Rizo L, Handy C, Umapathi P, Eagle A, Shilling C, et al
Tesamorelin is a highly researched peptide, findings to these clinical studies have found that Tesamorelin can have the following applications: Reduction of Visceral Fat Tesamorelin reduces visceral fat through its targeted mechanism of action, which begins by mimicking growth hormone-releasing hormone (GHRH)
In postmenopausal women, GPER overexpression correlates with an increased risk of type 2 diabetes and metabolic syndrome, and GPER antagonists may counteract these adverse metabolic outcomes [278]
The MS source temperature was fixed at 150 C, the desolvation temperature was set at 500 C, and the capillary voltages were kept at 3.20 kV or 3 kV for ESI + and ESI modes, respectively